PARK2 can inhibit the JAK2/STAT3/VEGF signaling pathway, and also through association with other genes and protein–protein interactions, regulate the network of growth pathways, thus becoming a vital tumor suppressor. This evidence concerns the gene JAK2 and neoplasm.